Skip to content
Luna Metabolic
Menu

Advertising disclosure We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.

Head-to-head for women

Good Girl Rx vs Pallas Health

Good Girl Rx and Pallas Health both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.

Good Girl Rx

Ranked #60 for women · Grade C

Best for: Women who want injectable, microdose, sublingual and brand-name routes on one account and are reading the safety page as carefully as the price page.

FDA warning letterFebruary 2026Read it ↗Visit Good Girl Rx
vs

Pallas Health

Higher score

Ranked #16 for women · Grade B−

Best for: Readers who want a general compounded GLP-1 program with unusually specific disclosure about who prescribes and who dispenses, and who can absorb a $597 charge four weeks after the $139 one — not readers looking for PCOS or perimenopause care, which Pallas does not offer.

Visit Pallas Health

The verdict for women

Higher Luna Fit Score: Pallas Health

Pallas Health edges out Good Girl Rx on the Luna Fit Score, 82 to 76 (B− vs C). Readers who want a general compounded GLP-1 program with unusually specific disclosure about who prescribes and who dispenses, and who can absorb a $597 charge four weeks after the $139 one — not readers looking for PCOS or perimenopause care, which Pallas does not offer. The reasoning behind that number is in the Pallas Health scorecard.

Good Girl Rx is still a genuine option — a women-first brand with the clearest contraception guidance we found anywhere in this ranking — and an FDA warning letter for how it labeled its compounded products, which is the reason it does not rank higher. Weigh the six women's-health factors below against your own priorities; what we found reviewing Good Girl Rx goes through each of them, and if neither of these two is the one, our ranked shortlist of Good Girl Rx alternatives widens the field.

Side-by-side on the six factors

Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.

Good Girl Rx Pallas Health
PCOS & hormonal suitability8574
Good
Pallas
Clinical oversight & labs6885
Good
Pallas
Price transparency7478
Good
Pallas
Nationwide access9294
Good
Pallas
Ongoing support7878
Good
Pallas
Cancellation fairness5584
Good
Pallas

Price, access & features

DetailGood Girl RxPallas Health
Luna Fit Score76/100 · C82/100 · B−
Overall rank#60#16
Semaglutide$179/mo month-to-month (from $134/mo on a 12-month prepay)$199/mo average — Pallas's own figure for $597 billed every 12 weeks, which is its only cadence; $139 covers the first 4 weeks, after which the next charge is $597 in one payment
Tirzepatide$329/mo month-to-month (from $235/mo on a 12-month prepay)$299/mo average — Pallas's own figure for $897 billed every 12 weeks, which is its only cadence; $179 covers the first 4 weeks, after which the next charge is $897 in one payment
CoverageAll 50 statesAll 50 states and Washington D.C. — asynchronous in 43; Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, West Virginia and D.C. require one video visit
Brand-name accessYesYes
Oral / sublingualYesInjection only

Good Girl Rx

Ranked #60 · Grade C

What we like

  • The best contraception guidance in the ranking: a two-month semaglutide washout before a planned pregnancy, and a warning that tirzepatide can blunt oral contraceptives for four weeks after starting AND after every dose increase
  • Four routes for each molecule — injection, microdose, sublingual dissolving tablet and brand — so a switch does not mean changing provider
  • Publishes a full per-plan price table for every product rather than one headline figure

The caveats

  • Every advertised 'from' price is a 12-month plan paid upfront, and dispensed prescriptions are final sale — a year's commitment with no way back
  • The microdose one-month rate is HIGHER than the standard injection one-month rate; the microdose discount exists only on prepay
  • Prices are described as an 'average monthly cost', so the flat-looking tiers may not be flat

Pallas Health

Ranked #16 · Grade B−

What we like

  • Names all six dispensing pharmacies in public — Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub and Foothills — with the 503A and 503B distinction explained, where almost everything else in this category names none
  • Names two prescribing physicians with their NPI numbers and links out to the NPPES registry so you can check them yourself: Dr. Ana Lisa Carr, MD (family medicine, NPI-verified, licensed in 15 states) and Dr. Kelly Tenbrink, MD (emergency medicine, NPI-verified, Tennessee and Florida). Pallas additionally claims obesity and addiction medicine board certifications for Dr. Carr, which NPPES does not carry either way
  • The advertised price is the checkout price — the homepage FAQ, the landing pages, the treatment pages and the live funnel all state the same four figures, and no different number appears at payment

The caveats

  • There is no month-to-month rung. The funnel renders no cadence selector at all: semaglutide is $139 for the first four weeks and then $597 billed every 12 weeks, so the second charge is $597 in one payment four weeks after the first — tirzepatide, $179 then $897 — and the advertised “$199/mo average” is that 12-week prepay divided by three rather than a price anyone is billed
  • Twelve weeks is not three months. On Pallas's own published renewal terms the charge recurs every 84 days — 4.35 times a year, not four — so semaglutide's first year is $139 + 4×$597 = $2,527, or $210.58/mo, and the steady state is $2,596 a year, about $216/mo, against $199 advertised. Tirzepatide runs $3,767 in year one ($313.92/mo) and about $3,900 a year after (~$325/mo) against $299. The advertised average understates the ongoing rate by roughly 8.7%
  • No women's-health program of any kind. Pallas's own women's-health category exists only as “coming soon”; there is no PCOS track, no perimenopause track and no cycle-aware protocol, and neither named physician is an OB-GYN or a women's-health specialist. What is on offer here is a general compounded GLP-1 program, and it should be read as one

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

More head-to-heads

Neither Good Girl Rx nor Pallas Health is only worth comparing with the other. Good Girl Rx is also written up against CoreAge Rx, 17 points apart on the Luna Fit Score — see how Good Girl Rx and CoreAge Rx compare on the Luna Fit Score. Pallas Health is also written up against CoreAge Rx, 11 points apart — see Pallas Health against CoreAge Rx, factor by factor.

Or browse the full comparison hub.